Form 8-K Tarsus Pharmaceuticals, For: Aug 05
http://archive.fast-edgar.com/20260806/AJZ2A22CJ222R282222522Z2PUGSV22SA282
Filed on: August 6, 2026
Form 8-K CareCloud, Inc. For: Aug 06
false
0001582982
0001582982
2026-08-06
2026-08-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Form 8-K Bausch & Lomb Corp For: Aug 05
false
0001860742
Bausch & Lomb Corp
0001860742
2026-08-05
2026-08-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM ... (continue reading...)
Form 8-K Scholar Rock Holding For: Aug 06
0001727196false00017271962026-08-062026-08-06
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 06, 2026
Scholar Rock Holding Corporation
(Exact name of Registrant as Specified in Its Charter)
More SEC Filings
View Older Stories-
Form 8-K REGENXBIO Inc. For: Aug 06
-
Form 10-Q TIC Solutions, Inc. For: Jun 30
-
Form 13F-NT Fullerton Fund Investmen For: Jun 30
-
Form 10-Q Monte Rosa Therapeutics, For: Jun 30
-
Form 10-Q Commerce.com, Inc. For: Jun 30
-
Form 10-Q Vistance Networks, Inc. For: Jun 30
-
Form 13F-HR AMF Tjanstepension AB For: Jun 30
-
Form 10-K OPEN TEXT CORP For: Jun 30
-
Form 10-Q Korro Bio, Inc. For: Jun 30
-
Form 8-K Tarsus Pharmaceuticals, For: Jul 31
-
Form 13F-NT Evans Investments Pte. For: Jun 30
-
Form 8-K SharonAI Holdings Inc. For: Aug 06
-
Form 8-K TELEFLEX INC For: Aug 06
-
Form 6-K ATS Corp /ATS For: Jun 28
-
Form 10-Q Core Natural Resources, For: Jun 30
-
Form 8-K Datadog, Inc. For: Aug 06
-
Form 8-K Vistance Networks, Inc. For: Aug 06
-
Form 13F-NT Esta Investments Pte. For: Jun 30
-
Form 6-K AXIA Energia S.A. For: Jun 30
-
Form 8-K OPEN TEXT CORP For: Aug 06
-
Form 8-K Commerce.com, Inc. For: Aug 06
-
Form 8-K Vistance Networks, Inc. For: Aug 04
-
Form 8-K Cullinan Therapeutics, For: Aug 06
-
Form 8-K Zoetis Inc. For: Aug 06
-
Form 8-K Smith Douglas Homes Corp For: Aug 06
-
Form SC TO-T Forte Biosciences, Inc. Filed by: ARGENX SE
-
Form 8-K Shift4 Payments, Inc. For: Aug 06
-
Form 10-Q TripAdvisor, Inc. For: Jun 30
-
Form 8-K Core Natural Resources, For: Aug 06
-
Form 10-Q Cartesian Therapeutics, For: Jun 30
-
Form 13F-NT Ellington Investments For: Jun 30
-
Form 8-K BENTLEY SYSTEMS INC For: Aug 06
-
Form 8-K Resolute Holdings Manage For: Aug 06
-
Form 6-K Pony AI Inc. For: Aug 06
-
Form 8-K Vital Farms, Inc. For: Aug 03
-
Form 13F-HR Marcho Partners LLP For: Jun 30
-
Form 10-Q PAPA JOHNS INTERNATIONAL For: Jun 28
-
Form 8-K IOVANCE BIOTHERAPEUTICS, For: Aug 06
-
Form 10-Q Immunocore Holdings plc For: Jun 30
-
Form 8-K BlackSky Technology Inc. For: Aug 06
-
Form 8-K Tecnoglass Holdings Inc. For: Aug 06
-
Form 8-K Viridian Therapeutics, For: Aug 06
-
Form 8-K LIGAND PHARMACEUTICALS For: Aug 06
-
Form 10-Q CPI Card Group Inc. For: Jun 30
-
Form 8-K Opus Genetics, Inc. For: Aug 06
-
Form 8-K Warner Bros. Discovery, For: Aug 06
-
Form 13F-NT Dahlia Investments Pte. For: Jun 30
-
Form 10-Q Amylyx Pharmaceuticals, For: Jun 30
-
Form 8-K Korro Bio, Inc. For: Aug 05
-
Form 10-Q Avalo Therapeutics, Inc. For: Jun 30

